ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62,000 | -53.0% | 60,400 | -36.9% | 0.00% | – |
| Q2 2021 | $132,000 | -23.7% | 95,700 | -5.9% | 0.00% | – |
| Q1 2021 | $173,000 | +16.1% | 101,725 | +77.8% | 0.00% | – |
| Q4 2016 | $149,000 | +156.9% | 57,200 | +163.4% | 0.00% | – |
| Q2 2016 | $58,000 | -14.7% | 21,718 | -1.4% | 0.00% | – |
| Q1 2016 | $68,000 | -69.8% | 22,018 | -62.3% | 0.00% | – |
| Q4 2015 | $225,000 | +5.1% | 58,346 | +49.8% | 0.00% | – |
| Q3 2014 | $214,000 | -46.4% | 38,937 | 0.0% | 0.00% | – |
| Q2 2014 | $399,000 | -44.4% | 38,937 | -34.8% | 0.00% | – |
| Q1 2014 | $717,000 | – | 59,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |